Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1999-10-7
pubmed:abstractText
Endothelial dysfunction, as observed in hypertension and atherosclerosis, is associated with a reduction in the bioavailability of endothelium-derived nitric oxide (NO). We tested the hypothesis that alterations in the soluble guanylyl cyclase (sGC) pathway may also contribute to the pathogenesis of hypertension. Therefore, we investigated the expression and activity of sGC in young (6 weeks) and aging (17 months) spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto rats (WKY). Endothelium-independent relaxation of aortic rings in response to the sGC activator YC-1 was attenuated in SHR, and expression of both alpha(1) and beta(1) subunits of heterodimeric sGC and the basal contents of cGMP were reduced specifically in SHR aorta. Moreover, mRNA expression of the cGMP receptor and effector protein cGMP-dependent protein kinase type Ialpha (cGKIalpha) was also reduced. Interestingly, downregulation of both sGC and cGKIalpha expression was observed in young, ie, normotensive SHR, whereas impairment of the endothelium-independent relaxation was found only in aging SHR. Accordingly, similar cGMP levels were reached in response to YC-1 in young SHR and young WKY, suggesting a compensatory increased sensitivity or effectiveness of the sGC pathway in young SHR. In aging SHR, however, increased sensitivity to YC-1 no longer compensated for the impairment of endothelium-independent relaxation, suggesting that other mechanisms were involved. In fact, endothelium-independent relaxations were partially restored by superoxide dismutase, suggesting a pathophysiological role of superoxide production, particularly at later disease stages. Thus, tissue-specific downregulation of components of the sGC/cGMP pathway is an early event in the pathogenesis of hypertension.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1524-4571
pubmed:author
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
534-41
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:10488056-Aging, pubmed-meshheading:10488056-Animals, pubmed-meshheading:10488056-Animals, Newborn, pubmed-meshheading:10488056-Aorta, pubmed-meshheading:10488056-Aorta, Thoracic, pubmed-meshheading:10488056-Cyclic GMP, pubmed-meshheading:10488056-Cyclic GMP-Dependent Protein Kinases, pubmed-meshheading:10488056-Endothelium, Vascular, pubmed-meshheading:10488056-Guanylate Cyclase, pubmed-meshheading:10488056-Hypertension, pubmed-meshheading:10488056-Isoenzymes, pubmed-meshheading:10488056-Male, pubmed-meshheading:10488056-Myocardium, pubmed-meshheading:10488056-RNA, Messenger, pubmed-meshheading:10488056-Rats, pubmed-meshheading:10488056-Rats, Inbred SHR, pubmed-meshheading:10488056-Rats, Inbred WKY, pubmed-meshheading:10488056-Solubility, pubmed-meshheading:10488056-Tissue Distribution, pubmed-meshheading:10488056-Vasodilation
pubmed:year
1999
pubmed:articleTitle
Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats.
pubmed:affiliation
Hoechst Marion Roussel, DG Cardiovascular, Frankfurt/Main, Germany. hartmut.ruetten@hmrag.com
pubmed:publicationType
Journal Article, In Vitro